Biotechnology company Eosera, Inc announced that Earwax MD®, an earwax impaction solution, will enhance its offering for audiologists and hearing aid centers at the annual audiology meeting, AAA 2018, in Nashville. Eosera will sell product directly and via various resellers for sale in-clinic. The company will also offer a sneak peek at one of several products to come, such as WaxBlaster MD™, a new rinsing device to be used after cleaning the ear canal with Earwax MD.
“Since last year, the market has responded remarkably well to Earwax MD,” said Elyse Dickerson, co-founder and CEO of Eosera, Inc. “In retailers carrying the product, dollar sales are up over 18% in the ear care category. This growth is primarily driven by the introduction of Earwax MD.”
“Audiologists have been looking for an easier way to treat patients with impacted earwax,” said Joe Griffin, co-founder and CSO. “Until now, audiologists often perform a manual extraction of the impacted wax, which can be very painful and time-consuming. Now, audiologists and hearing aid centers can use Earwax MD in their offices and also sell the product so that patients can self-treat in the comfort of their own homes prior to their appointments to fit for hearing aids.”
Apart from creating ear care products, Eosera is said to be positioning itself as the go-to resource for education and information on ear health that the market can rely on.
“To this end, Eosera will continue to invest in clinical studies that prove the safety and efficacy of our products,” said Griffin.
At the audiology conference, #AAAConf18, attendees can obtain more information about Earwax MD and WaxBlaster MD at Booth 434. Additionally, audiologists and hearing aid centers can simply click here to see where to buy Earwax MD and request more information.